СИБР (хирургическое лечение и профилактика)

73. Flint, H. J. Interactions and competition within the microbial community of the human colon: links between diet and health / H. J. Flint, S. H. Duncan, K. P. Scott, P. Louis // Environ. Microbiol. 2007;9:1101–11.

74. Ley, R. E. Ecological and evolutionary forces shaping microbial diversity in the human intestine / R. E. Ley, D. A. Peterson, J. I. Gordon // Cell. 2006;124:837–48.

75. Freter, R. Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora / R. Freter, H. Brickner, M. Botney et al. // Infect. Immun. 1983; 39:676–85.

76. Juge, N. Microbial adhesins to gastrointestinal mucus / N. Juge // Trends Microbiol. 2012;20:30–9.

77. Marteyn, B. Breathing life into pathogens: the influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract / B. Marteyn, F. B. Scorza, P. J. Sansonetti, C. Tang // Cell. Microbiol. 2011;13:171–6.

78. Altier, C. Genetic and environmental control of salmonella invasion / C. Altier // J. Microbiol. 2005; 43:85–92.

79. Marteyn, B. Modulation ofShigellavirulence in response to available oxygen in vivo / B. Marteyn, N. P. Wes, D. F. Browning et al. // Nature. 2010;465:355–8

80. Dobson. A. Bacteriocin production: a probiotic trait? / A. Dobson, P. D. Cotter, R. P. Ross, C. Hill // Appl. Environ. Microbiol. 2012;78:1–6.

81. Corr, S. C. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens / S. C. Corr, C. Hill, C. G. Gahan // Adv Food Nutr Res. 2009;56:1–15.

82. Gong, H. S. Mode of action of plantaricin MG, a bacteriocin active againstSalmonella typhimurium / H. S. Gong, X. C. Meng, H. J. Wang // J. Basic. Microbiol. 2010;50 (Suppl. 1):S37–45.

83. Dabard, J. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavusstrain isolated from human feces // J. Dabard, C. Bridonneau, C. Phillipe et al. // Appl. Environ. Microbiol. 2001;67:4111–8.

84. Rea, M. C. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity againstClostridium difficile / M. C. Rea, C. S. Sit, E. Clayton et al. // Proc. Natl. Acad. Sci. USA. 2010;107:9352–7.

85. Camilli, A. Bacterial small-molecule signaling pathways / A. Camilli, B. L. Bassler // Science. 2006; 311:1113–6.

86. Gantois, I. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression / I. Gantois, R. Ducatelle, F. Pasmans et al. // Appl.Environ. Microbiol. 2006;72:946–9.

87. Monack, D. M. Persistent bacterial infections: the interface of the pathogen and the host immune system / D. M. Monack, A. Mueller, S. Falkow // Nat. Rev. Microbiol. 2004;2:747–65.

88. Cherrington, C. A. Short-chain organic acids at pH 5.0 killEscherichia coliandSalmonellaspp. without causing membrane perturbation / C. A. Cherrington, M. Hinton, G. R. Pearson, I. Chopra // J. Appl. Bacteriol. 1991;70:161–5.

89. Duncan, S. H. The role of pH in determining the species composition of the human colonic microbiota / S. H. Duncan, P. Louis, J. M. Thomson, H. J. Flint // Environ. Microbiol. 2009;11:2112–22.

90. Shin, R. Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coliO157:H7 / R. Shin, M. Suzuki, Y. Morishita // J. Med. Microbiol. 2002; 51:201–6.

91. Veiga, P. Bifidobacterium animalissubsp.lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes / P. Veiga, C. A. Gallini, Beal Cet al // Proc. Natl. Acad. Sci. USA. 2010;107:18132–7.

92. Wong, J. M. Colonic health: fermentation and short chain fatty acids / J. M. Wong, R. de Souza, C. W. Kendall et al. // J. Clin. Gastroenterol. 2006;40:235–43.

93. Fukuda, S. Bifidobacteria can protect from enteropathogenic infection through production of acetate / S. Fukuda, H. Toh, K. Hase et al. // Nature. 2011;469:543–7.

94. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. / D. Artis // Nat. Rev. Immunol. 2008;8:411–20.

95. Atarashi, K. ATP drives lamina propria TH17 cell differentiation / K. Atarashi, J. Nishimura, T. Shima et al. // Nature. 2008; 455:808–12.

96. Satoh-Takayama, N. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense / N. Satoh-Takayama, C. A. Vosshenrich, S. LesjeanPottier et al. // Immunity. 2008;29:958–70.

97. Lee, Y. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis / Y. K. Lee, J. S. Menezes, Y. Umesaki, S. K. Mazmanian // Proc. Natl. Acad. Sc.i USA. 2011;108 (Suppl. 1):4615–22.

98. Josefowicz, S. Z. Extrathymically generated regulatory T cells control mucosal TH2 inflammation / S. Z. Josefowicz, R. E. Niec, H. Y. Kim et al. // Nature. 2012;482:395–9.

99. Round, J. L. The gut microbiota shapes intestinal immune responses during health and disease / J. L. Round, S. K. Mazmanian // Nat. Rev. Immunol. 2009;9:313–23.